Merck, a leading science and technology company on Wednesday announced the opening of its new office in Nigeria.
The new office, which is the company’s first in the country, it said, was part of its strategy to grow its market share in the West African region.
The CEO-elect of Merck, Stefan Oschmann; President of North & West Africa, of the company, Karim Bendhaou, said this at a media briefing.
They also launched the Muse Auto CD4/CD4%System(1), a compact and easy to use HIV/AIDS Diagnostic Kit, which is able to monitor the progression of the HIV/AIDS virus in patients.
“Nigeria is an evident choice for us. With a population that is known for its entrepreneurial spirit and innovative ideas, this is a perfect match with Merck,” Oschmann said, adding that “Nigeria, Africa’s largest economy, has one of the fastest growing economies in the world (2) and we believe that through our high quality and innovative Healthcare and Life Science specialty products and services we can contribute to that growth.”
Besides a presence through their products, the company said it had been working closely with the Nigerian government and international organisations to increase access to health solutions in the country.
Merck, within the scope of its responsible corporate governance, said it was committed to improving access to health for underserved populations in low-and middle-income countries. Health, along with environment and culture, represent Merck’s strategic spheres of activities that are part of the company’s Corporate Responsibility Strategy.
The Group’s Executive Board is visiting 10 African countries this week to underscore its commitment and rising importance of the continent.